Journal
JOURNAL OF IMMUNOLOGY RESEARCH
Volume 2020, Issue -, Pages -Publisher
HINDAWI LTD
DOI: 10.1155/2020/8821181
Keywords
-
Categories
Funding
- Research Institute for Health Science, Chiang Mai University, Thailand
- Guangdong Provincial Key Laboratory of Food Quality and Safety, College of Food Science, South China Agricultural University, Guangzhou, People's Republic of China
Ask authors/readers for more resources
Amyloid beta peptides (A beta 1-42) have been found to be associated with the cause of Alzheimer's disease (AD) and dementia. Currently, methods for detecting A beta 1-42 are complicated and expensive. The present study is aimed at developing an indirect competitive enzyme-linked immunosorbent assay (ic-ELISA) to detect A beta 1-42 by using a polyclonal antibody from alpaca, an application used in urine samples. The serum was collected from the alpaca after immunizing it with A beta 1-42 at 500 mu g/injection 5 times. The ic-ELISA was developed and showed a half-maximal inhibitory concentration (IC50) of 103.20 ng/ml. The limit of detection (LOD) was 0.39 ng/100 mu l. The cross-reactivity was tested with A beta 1-40 and 8 synthesized peptides that had sequence similarities to parts of A beta 1-42. The cross-reactivity of A beta 1-40 and peptide 1 (DAEFRHDSGYE) was 55% and 69.4%, respectively. The ic-ELISA was applied to analyze A beta 1-42 in the urine and precipitated protein urine samples. This method can be used for detecting a normal level of total soluble A beta (approximately 1 ng in 5 mg of precipitated urine protein) and can be used for detecting the early stages of AD. It is considered to be an easy and inexpensive method for monitoring and diagnosing AD.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available